Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis

BACKGROUND: The efficacy and safety of combination therapy with adalimumab (ADA) plus intensive granulocyte and monocyte adsorptive apheresis (GMA) (two sessions per week) for the treatment of refractory ulcerative colitis (UC) have not been previously evaluated. METHODS: This retrospective study ev...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Med Res
Main Authors: Tanida, Satoshi, Mizoshita, Tsutomu, Nishie, Hirotada, Ozeki, Keiji, Katano, Takahito, Kubota, Eiji, Kataoka, Hiromi, Kamiya, Takeshi, Joh, Takashi
Formato: Artigo
Idioma:Inglês
Publicado: Elmer Press 2015
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4596271/
https://ncbi.nlm.nih.gov/pubmed/26491502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2333w
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares